In the past, many listed companies have issued preference shares as bonus. In this article we will try to analyze the different facets of issuing preference shares as a bonus.
TVS Motor Company Limited ("TVS" or "Company") is engaged in manufacturing two & three wheelers' vehicles. The Company has state of art manufacturing facilities in Hosur, Mysuru and Nalagarh in India and Karawang in Indonesia. The equity shares of the company are listed on nationwide bourses.
The Proposed Transaction
The Board of Directors of the Company at its meeting inter alia, has approved the Scheme of Arrangement between the Company and its shareholders under Sections 230 to 232 of the Companies Act, 2013 ("Scheme"), which, inter-alia, provides for issuance and allotment of cumulative non-convertible redeemable preference shares ("NCRPS") by way of bonus.
Bonus Ratio:
4 NCRPS (Cumulative non-convertible Preference Share) of INR 10/- each fully paid up of the Company for every 1 equity share of INR 1 each fully paid up held as on the Record Date.
The dividend rate will be 6% per annum.
The NCRPS shall be redeemed on the expiry of 12 months from the date of allotment of the said NCRPS.
Proposed to be listed on the NSE (National Stock Exchange of India) Limited and BSE (Bombay Stock Exchange) Limited i.e., the stock exchanges on which the equity shares of the Company are listed.
Rationale for issuance of bonus shares:
The company has built up substantial reserves over the years from its retained profit which is well above the company's current and likely business needs.
Accordingly, the company proposes to distribute surplus funds amongst shareholders.
この記事は M & A Critique の May 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は M & A Critique の May 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Raymond Group continues Segregation of its Business Verticals
After successful demerger of \"Lifestyle Business,\" Raymond Limited announced yet another restructuring to unlock further value for stakeholders.
Ultratech Cements adds India Cement in its shopping cart
India's Cement Industry is poised for consolidation. In recent past we have seen multiple large & small acquisitions in cement segment for consolidating positions.
Valor Estate Limited: "Diversification" to "Sepration" of Hospitality Business
“From investments in hospitality business, the demerger transaction will enable VEL to start its construction in hospitality”
SIEMENS Energy to be a separate entity in alignment with global strategy
Siemens AG announced its Vision 2020+ which included the spin-off of its Gas & Power [G&P) i.e., Energy Business into Siemens Energy.
Arvind Group separates its Advanced Material Business for independent growth trajectory
Advanced Material Business (AMD) of Arvind Limited focuses on advanced materials and caters to customer needs across the textile value chain, including specialty yarns, fabrics, and ready-made products.
Merger for bail-out from debt obligation
Ind Swift Limited (herein after also referred to as 'ISL' or 'Transferor Company') is engaged in the business of manufacturing of Pharmaceutical Products.
Batliboi Ltd. merging its associate company
Batliboi Limited has a history of collaborations with various foreign technical partners and has subsidiaries like Hydraulic & General Engineers Ltd. and Batliboi International Ltd. In March 2024, the board of Directors of Batliboi Limited accorded their approval for the merger of promoter owned private company with itself.
TVS Motors issuances of convertible preference shares as bonus instead of dividend
Recently, well known auto manufacturer announced the issuance of preference shares as a bonus to all equity shareholders.
Aditya Birla Fashion & Retails Scheme to undo its consolidation
Corporate restructuring saga continues for Aditya Birla Group.
Advent International to combine its listed & private entity business
Recently, Advent International announced the merger of its privately held pharma company into recently acquired listed pharma company.